0
RSS Email Alerts
Please Wait... Processing your request... Please Wait.

JAMA | 
Editorial | 
Deepak L. Bhatt, MD, MPH
JAMA. 2011;305(18):1908-1909. doi:10.1001/jama.2011.600.

JAMA | 
Original Contribution |  FREE
Samer S. Najjar, MD; Sunil V. Rao, MD; Chiara Melloni, MD, MHS; et al.
JAMA. 2011;305(18):1863-1872. doi:10.1001/jama.2011.592.
Includes: Supplemental Content

JAMA Internal Medicine | 
Original Investigation |  FREE
Michael A. Fischer, MD, MS; Charles A. Morris, MD, MPH; Wolfgang C. Winkelmayer, MD, ScD; et al.
Arch Intern Med. 2007;167(8):840-846. doi:10.1001/archinte.167.8.840.

JAMA Internal Medicine | 
Editor's Correspondence | 
Jerry L. Spivak, MD
Arch Intern Med. 2006;166(17):1923-1924. doi:10.1001/archinte.166.17.1923-b.

JAMA Internal Medicine | 
Review Article |  FREE
David H. Henry, MD; Peter Bowers, MD; Michael T. Romano, PhD; et al.
Arch Intern Med. 2004;164(3):262-276. doi:10.1001/archinte.164.3.262.

JAMA Pediatrics | 
Article |  FREE
Shahid Nazir, MD; Ricardo L. Peverini, MD; Douglas D. Deming, MD; et al.
Arch Pediatr Adolesc Med. 2002;156(6):540-544. doi:10.1001/archpedi.156.6.540.

JAMA Neurology | 
Observation |  FREE
Pasquale F. Finelli, MD; Matthew D. Carley, MD
Arch Neurol. 2000;57(2):260-262. doi:10.1001/archneur.57.2.260.

Sign In

Register for a FREE personal account

and access these and other features:

Register Now

Want to Subscribe?

Learn More about subscription options.

Don't have Access?

Register and get free email Table of Contents alerts, saved searches, PowerPoint downloads, CME quizzes, and more

Subscribe for full-text access to content from 1998 forward and a host of useful features

Activate your current subscription (AMA members and current subscribers)

From The JAMA Network
JAMA
Editorial  | 
Evaluation of Agents to Reduce Infarct Size:  It Can Be Quite REVEALing
Deepak L. Bhatt, MD, MPH
JAMA
Original Contribution  | 
Intravenous Erythropoietin in Patients With ST-Segment Elevation Myocardial Infarction:  REVEAL: A Randomized Controlled Trial
Samer S. Najjar, MD; Sunil V. Rao, MD; Chiara Melloni, MD, MHS; et al.
JAMA Internal Medicine
Original Investigation  | 
Nononcologic Use of Human Recombinant Erythropoietin Therapy in Hospitalized Patients
Michael A. Fischer, MD, MS; Charles A. Morris, MD, MPH; Wolfgang C. Winkelmayer, MD, ScD; et al.
JAMA Internal Medicine
Editor's Correspondence  | 
Erythropoietin Resistance During Androgen Deficiency—Reply
Jerry L. Spivak, MD